Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003680 |
---|---|
Receipt number | R000004461 |
Scientific Title | Phase II study of Pemetrexed and Carboplatin plus Bevacizumab for advanced non-small cell lung cancer |
Date of disclosure of the study information | 2010/06/03 |
Last modified on | 2013/05/31 14:06:45 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/31 17:34:10 | ||
2 | Update | 2010/05/31 17:44:16 | Public title Acronym |
|
3 | Update | 2010/05/31 17:44:33 | Narrative objectives1 |
|
4 | Update | 2011/11/26 20:32:00 | Organization Organization Division name Organization Organization Division name Name of person sending information Organization Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2012/02/27 18:59:40 | Recruitment status |
|
6 | Update | 2012/11/30 17:34:49 | Publication of results |
|
7 | Update | 2013/05/31 14:06:45 | Recruitment status |